MyAverix Finance MyAverix Finance

F

BIG PHARMA SPLIT CL.A (XN4)

BIG PHARMA SPLIT CL.A (XN4) is listed on F. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for XN4

P/E ratio
18.00

BIG PHARMA SPLIT CL.A (XN4) — FAQ

What is XN4's P/E ratio?

The price-to-earnings (P/E) ratio for BIG PHARMA SPLIT CL.A (XN4) is 18.00 (data as of 2026-05-23).

Does BIG PHARMA SPLIT CL.A pay a dividend?

Dividend yield is not available in the current snapshot for BIG PHARMA SPLIT CL.A (XN4). Check the MyAverix Finance app for the latest dividend data.

What exchange is XN4 listed on?

XN4 is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play